Methods for synthesizing nucleotide analogues with disulfide linkers
The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3′-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.
1. A method, comprising: a) providing a 5′-O-(tert-butyldimethvisilyl)-iodo-2′-deoxynucleoside; b) treating said 5′-O-(tert-(butyldimethylsilyl)-iodo-2′-deoxynucleoside so as to produce a 5′-O-(tert-butyldimethylsilyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside intermediate; c) treating said 5′-O-(tert-butyldimethylsilyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside intermediate so as to produce a 5′-O-(tert-butyldimethylsilyl)-3′-O-(methyl-thio-2,4,6-trimethoxyphenyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside intermediate.
2. The method of claim 1 , wherein said treating of step c) comprises exposing said 5′-O-(tert-butyldimethylsilyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside intermediate to (2,4,6-trimethoxyphenyl)methanethiol.
3. The method of claim 1 , further comprising d) treating said 5′-O-(tert-butyldimethylsilyl)-3′-O-(methyl-thio-2,4,6-trimethoxyphenyl)-N-trifluroroacetyl-propargylamine-2′-deoxynucleoside intermediate so as to produce a 5′-OH-3′-O-(2,4,6-trimethoxyphenyl-thio-methyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside intermediate.
4. The method of claim 3 , wherein said treating of step d) comprises exposing said 5′-O-(tert-butyldimethylsilyl)-3′-O-(2,4,6-trimethoxyphenyl-thio-methyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside to tetra-n-butylammonium fluoride.
5. The method of claim 3 , further comprising c) treating said 5′-OH-3′-O-(2,4,6-trimethoxyphenyl-thio-methyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside intermediate so as to produce a triphosphate of 3′-O-(2,4,6-trimethoxyphenyl-thio-methyl)-propargylamine-2′-deoxynucleoside intermediate.
6. The method of claim 5 , wherein said treating, of step e) comprises exposing said 5′-OH-3’-O-(2,4,6-trimethoxyphenyl-thio-methyl)-N-trifluoroacetyl-propargylamine-2′-deoxynucleoside intermediate to (MeO) 3 PO with POCl 3 and Bu 3 N.
7. The method of claim 5 , further comprising f) treating said triphosphate of 3′-O-(2,4,6-trimethoxyphenyl-thio-methyl)-propargylamine-2′-deoxynucleoside intermediate so as to produce a triphosphate of 3 ‘-O-(alkyl-dithiomethyl)-propargylamine-2′-deoxynucleoside.
8. The method of claim 7 , wherein said treating of step f) comprises exposing triphosphate of 3′-O-(2,4,6-trimethoxyphenyl-thio-methyl)-propargylamine-2′-deoxynucleoside intermediate to an alkyl sulfide.